Drugs / MEDI-559
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00767416 | Oct 2008 → Dec 2011 | — | MedImmune LLC | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MEDI-559 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00767416 ↗ |
| Modality | Vaccine | “live attenuated intranasal vaccine candidate” PMID 24204744 ↗ Oct 2013 |
| Route | Intranasal | “live attenuated intranasal vaccine” NCT00767416 ↗ |